FENNEC PHARMACEUTICALS INC. (FENC) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

1996: $01997: -$37.0K1998: -$435.0K1999: $242.0K2000: $47.0K2001: $9.79M2002: $6.07M2003: $698.0K2004: $16.65M2005: $11.08M2006: $1.27M2007: $14.15M2008: $3.05M2009: $406.0K2010: -$4.92M2011: -$119.0K2012: -$4.96M2013: -$1.46M2014: $613.0K2015: $548.0K2016: $3.57M2017: $26.76M2018: $21.31M2019: $11.88M2020: $29.07M2021: $15.77M2022: -$2.57M2023: -$11.62M2024: -$5.87M2025: $35.47M$35.47M
1996Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$35.47M+704.1%
2024-$5.87M+49.5%
2023-$11.62M-352.4%
2022-$2.57M-116.3%
2021$15.77M-45.7%
2020$29.07M+144.8%
2019$11.88M-44.3%
2018$21.31M-20.3%
2017$26.76M+649.5%
2016$3.57M+551.5%
2015$548.0K-10.6%
2014$613.0K+142.1%
2013-$1.46M+70.6%
2012-$4.96M-4065.5%
2011-$119.0K+97.6%
2010-$4.92M-1313.1%
2009$406.0K-86.7%
2008$3.05M-78.4%
2007$14.15M+1015.8%
2006$1.27M-88.6%
2005$11.08M-33.5%
2004$16.65M+2286.0%
2003$698.0K-88.5%
2002$6.07M-38.0%
2001$9.79M+20734.0%
2000$47.0K-80.6%
1999$242.0K+155.6%
1998-$435.0K-1075.7%
1997-$37.0K
1996$0